{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:11:01Z","timestamp":1790723461882,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,29]]},"DOI":"10.7759\/cureus.117175","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:41:36Z","timestamp":1790721696000},"source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic Differences in Adult-Onset and Juvenile-Onset Huntington\u2019s Disease and the Potential Role of Neurodevelopment"],"prefix":"10.7759","author":[{"given":"Vasundhara","family":"Anjur Thupil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Satchidanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington's disease: the good, the bad, and the ugly","volume":"5","author":"Kumar A","year":"2016","unstructured":"Kumar A, Ratan RR. Oxidative stress and Huntington's disease: the good, the bad, and the ugly. J Huntingtons Dis. 2016, 5:217-37. 10.3233\/JHD-160205","journal-title":"J Huntingtons Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-180339","article-title":"Clinical presentation and features of juvenile-onset Huntington's disease: a systematic review","volume":"8","author":"Cronin T","year":"2019","unstructured":"Cronin T, Rosser A, Massey T. Clinical presentation and features of juvenile-onset Huntington's disease: a systematic review. J Huntingtons Dis. 2019, 8:171-9. 10.3233\/JHD-180339","journal-title":"J Huntingtons Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28823","article-title":"Juvenile-onset Huntington disease pathophysiology and neurodevelopment: a review","volume":"37","author":"Bakels HS","year":"2022","unstructured":"Bakels HS, Roos RA, van Roon-Mom WM, de Bot ST. Juvenile-onset Huntington disease pathophysiology and neurodevelopment: a review. Mov Disord. 2022, 37:16-24. 10.1002\/mds.28823","journal-title":"Mov Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007355","article-title":"Brain structure in juvenile-onset Huntington disease","volume":"92","author":"Tereshchenko A","year":"2019","unstructured":"Tereshchenko A, Magnotta V, Epping E, et al.. Brain structure in juvenile-onset Huntington disease. Neurology. 2019, 92:e1939-47. 10.1212\/WNL.0000000000007355","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13349","article-title":"Clinical characterization of dystonia in adult patients with Huntington's disease","volume":"24","author":"van de Zande NA","year":"2017","unstructured":"van de Zande NA, Massey TH, McLauchlan D, et al.. Clinical characterization of dystonia in adult patients with Huntington's disease. Eur J Neurol. 2017, 24:1140-7. 10.1111\/ene.13349","journal-title":"Eur J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.124552","article-title":"Exploring Huntington's disease from a neurodevelopmental perspective","volume":"22","author":"Huang C","year":"2026","unstructured":"Huang C, Zheng X, Li W, et al.. Exploring Huntington's disease from a neurodevelopmental perspective. Int J Biol Sci. 2026, 22:1233-46. 10.7150\/ijbs.124552","journal-title":"Int J Biol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.12.1243","article-title":"Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration","volume":"10","author":"Peters\u00e9n A","year":"2001","unstructured":"Peters\u00e9n A, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P, Sulzer D. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet. 2001, 10:1243-54. 10.1093\/hmg\/10.12.1243","journal-title":"Hum Mol Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad275","article-title":"Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration","volume":"146","author":"Estevez-Fraga C","year":"2023","unstructured":"Estevez-Fraga C, Altmann A, Parker CS, et al.. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration. Brain. 2023, 146:4532-46. 10.1093\/brain\/awad275","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00190","article-title":"Effect of neuroinflammation on synaptic organization and function in the developing brain: implications for neurodevelopmental and neurodegenerative disorders","volume":"11","author":"Mottahedin A","year":"2017","unstructured":"Mottahedin A, Ardalan M, Chumak T, Riebe I, Ek J, Mallard C. Effect of neuroinflammation on synaptic organization and function in the developing brain: implications for neurodevelopmental and neurodegenerative disorders. Front Cell Neurosci. 2017, 11:190. 10.3389\/fncel.2017.00190","journal-title":"Front Cell Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03441-0","article-title":"Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown","volume":"12","author":"Bi M","year":"2021","unstructured":"Bi M, Du X, Jiao Q, Chen X, Jiang H. Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown. Cell Death Dis. 2021, 12:154. 10.1038\/s41419-021-03441-0","journal-title":"Cell Death Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041432","article-title":"Endothelial dysfunction in Huntington's disease: pathophysiology and therapeutic implications","volume":"26","author":"Hu N","year":"2025","unstructured":"Hu N, Chen Z, Zhao X, Peng X, Wu Y, Yang K, Sun T. Endothelial dysfunction in Huntington's disease: pathophysiology and therapeutic implications. Int J Mol Sci. 2025, 26:1432. 10.3390\/ijms26041432","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00796-3","article-title":"Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms","volume":"37","author":"Wang X","year":"2022","unstructured":"Wang X, Cui L, Ji X. Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms. Metab Brain Dis. 2022, 37:51-66. 10.1007\/s11011-021-00796-3","journal-title":"Metab Brain Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12502","article-title":"Survival, mortality, causes and places of death in a European Huntington's disease prospective cohort","volume":"4","author":"Rodrigues FB","year":"2017","unstructured":"Rodrigues FB, Abreu D, Dam\u00e1sio J, Goncalves N, Correia-Guedes L, Coelho M, Ferreira JJ. Survival, mortality, causes and places of death in a European Huntington's disease prospective cohort. Mov Disord Clin Pract. 2017, 4:737-42. 10.1002\/mdc3.12502","journal-title":"Mov Disord Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.16022","article-title":"Survival of Korean Huntington's disease patients","volume":"9","author":"Kim HJ","year":"2016","unstructured":"Kim HJ, Shin CW, Jeon B, Park H. Survival of Korean Huntington's disease patients. J Mov Disord. 2016, 9:166-70. 10.14802\/jmd.16022","journal-title":"J Mov Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30294-1","article-title":"Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis","volume":"17","author":"Fusilli C","year":"2018","unstructured":"Fusilli C, Migliore S, Mazza T, et al.. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis. Lancet Neurol. 2018, 17:986-993. 10.1016\/S1474-4422(18)30294-1","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10030155","article-title":"Diagnosing juvenile Huntington's disease: an explorative study among caregivers of affected children","volume":"10","author":"Oosterloo M","year":"2020","unstructured":"Oosterloo M, Bijlsma EK, Die-Smulders C, Roos RA. Diagnosing juvenile Huntington's disease: an explorative study among caregivers of affected children. Brain Sci. 2020, 10:155. 10.3390\/brainsci10030155","journal-title":"Brain Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-231523","article-title":"Clinical review of juvenile Huntington's disease","volume":"13","author":"Oosterloo M","year":"2024","unstructured":"Oosterloo M, Touze A, Byrne LM, et al.. Clinical review of juvenile Huntington's disease. J Huntingtons Dis. 2024, 13:149-61. 10.3233\/JHD-231523","journal-title":"J Huntingtons Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2023-0142","article-title":"Latest advances on new promising molecular-based therapeutic approaches for Huntington's disease","volume":"12","author":"Cheng Y","year":"2024","unstructured":"Cheng Y, Zhang S, Shang H. Latest advances on new promising molecular-based therapeutic approaches for Huntington's disease. J Transl Int Med. 2024, 12:134-47. 10.2478\/jtim-2023-0142","journal-title":"J Transl Int Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002085","article-title":"Juvenile Huntington's disease: a population-based study using the general practice research database","volume":"3","author":"Douglas I","year":"2013","unstructured":"Douglas I, Evans S, Rawlins MD, Smeeth L, Tabrizi SJ, Wexler NS. Juvenile Huntington's disease: a population-based study using the general practice research database. BMJ Open. 2013, 3:e002085. 10.1136\/bmjopen-2012-002085","journal-title":"BMJ Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.15","article-title":"The personal experience of parenting a child with juvenile Huntington's disease: perceptions across Europe","volume":"21","author":"Eatough V","year":"2013","unstructured":"Eatough V, Santini H, Eiser C, et al.. The personal experience of parenting a child with juvenile Huntington's disease: perceptions across Europe. Eur J Hum Genet. 2013, 21:1042-8. 10.1038\/ejhg.2013.15","journal-title":"Eur J Hum Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0759-9","article-title":"Juvenile Huntington's disease: diagnostic and treatment considerations for the psychiatrist","volume":"19","author":"Quigley J","year":"2017","unstructured":"Quigley J. Juvenile Huntington's disease: diagnostic and treatment considerations for the psychiatrist. Curr Psychiatry Rep. 2017, 19:9. 10.1007\/s11920-017-0759-9","journal-title":"Curr Psychiatry Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/1359105307084307","article-title":"The impact of juvenile Huntington's disease on the family: the case of a rare childhood condition","volume":"13","author":"Brewer HM","year":"2008","unstructured":"Brewer HM, Eatough V, Smith JA, Stanley CA, Glendinning NW, Quarrell OW. The impact of juvenile Huntington's disease on the family: the case of a rare childhood condition. J Health Psychol. 2008, 13:5-16. 10.1177\/1359105307084307","journal-title":"J Health Psychol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1367493507073060","article-title":"Caring for a child with juvenile Huntington's disease: helpful and unhelpful support","volume":"11","author":"Brewer HM","year":"2007","unstructured":"Brewer HM, Smith JA, Eatough V, Stanley CA, Glendinning NW, Quarrell OW. Caring for a child with juvenile Huntington's disease: helpful and unhelpful support. J Child Health Care. 2007, 11:40-52. 10.1177\/1367493507073060","journal-title":"J Child Health Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2008.04946.x","article-title":"The emotional experiences of family carers in Huntington disease","volume":"65","author":"Williams JK","year":"2009","unstructured":"Williams JK, Skirton H, Paulsen JS, et al.. The emotional experiences of family carers in Huntington disease. J Adv Nurs. 2009, 65:789-98. 10.1111\/j.1365-2648.2008.04946.x","journal-title":"J Adv Nurs"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30334-X","article-title":"Juvenile Huntington's disease: left behind?","volume":"17","author":"Stout JC","year":"2018","unstructured":"Stout JC. Juvenile Huntington's disease: left behind?. Lancet Neurol. 2018, 17:932-933. 10.1016\/S1474-4422(18)30334-X","journal-title":"Lancet Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213525","article-title":"Comparison of the clinical spectrum of juvenile- and adult-onset Huntington disease: a national cohort and enroll-HD observational study","volume":"104","author":"Bakels HS","year":"2025","unstructured":"Bakels HS, van der Zwaan KF, Van Zwet E, et al.. Comparison of the clinical spectrum of juvenile- and adult-onset Huntington disease: a national cohort and enroll-HD observational study. Neurology. 2025, 104:e213525. 10.1212\/WNL.0000000000213525","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14287","article-title":"No evidence of early developmental delay in juvenile-onset Huntington's disease patients","volume":"12","author":"Olson L","year":"2025","unstructured":"Olson L, Dickens S, Schultz JL, Neema M, Nopoulos PC. No evidence of early developmental delay in juvenile-onset Huntington's disease patients. Mov Disord Clin Pract. 2025, 12:346-52. 10.1002\/mdc3.14287","journal-title":"Mov Disord Clin Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin MT","year":"2006","unstructured":"Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006, 443:787-95. 10.1038\/nature05292","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3772","article-title":"Genetics of Huntington disease","volume":"35","author":"Mahalingam S","year":"2014","unstructured":"Mahalingam S, Levy LM. Genetics of Huntington disease. AJNR Am J Neuroradiol. 2014, 35:1070-2. 10.3174\/ajnr.A3772","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.916019","article-title":"Synaptic and functional alterations in the development of mutant huntingtin expressing hiPSC-derived neurons","volume":"9","author":"Dinamarca MC","year":"2022","unstructured":"Dinamarca MC, Colombo L, Tousiaki NE, M\u00fcller M, Pecho-Vrieseling E. Synaptic and functional alterations in the development of mutant huntingtin expressing hiPSC-derived neurons. Front Mol Biosci. 2022, 9:916019. 10.3389\/fmolb.2022.916019","journal-title":"Front Mol Biosci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74042-8","article-title":"Wild-type huntingtin regulates human macrophage function","volume":"10","author":"O'Regan GC","year":"2020","unstructured":"O'Regan GC, Farag SH, Ostroff GR, Tabrizi SJ, Andre R. Wild-type huntingtin regulates human macrophage function. Sci Rep. 2020, 10:17269. 10.1038\/s41598-020-74042-8","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/18796397251395783","article-title":"Huntington's as a developmental disorder: molecular and neuropathologic considerations","volume":"15","author":"Shin MR","year":"2026","unstructured":"Shin MR, Hefti MM. Huntington's as a developmental disorder: molecular and neuropathologic considerations. J Huntingtons Dis. 2026, 15:226-34. 10.1177\/18796397251395783","journal-title":"J Huntingtons Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51216-w","article-title":"Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure","volume":"15","author":"Lisowski P","year":"2024","unstructured":"Lisowski P, Lickfett S, Rybak-Wolf A, et al.. Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure. Nat Commun. 2024, 15:7027. 10.1038\/s41467-024-51216-w","journal-title":"Nat Commun"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052282","article-title":"Altered huntingtin-chromatin interactions predict transcriptional and epigenetic changes in Huntington's disease","volume":"18","author":"Pearl JR","year":"2025","unstructured":"Pearl JR, Shetty AC, Cantle JP, et al.. Altered huntingtin-chromatin interactions predict transcriptional and epigenetic changes in Huntington's disease. Dis Model Mech. 2025, 18:dmm052282. 10.1242\/dmm.052282","journal-title":"Dis Model Mech"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104720","article-title":"Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of Huntington's disease","volume":"94","author":"Tano V","year":"2023","unstructured":"Tano V, Utami KH, Yusof NA, B\u00e9gin J, Tan WW, Pouladi MA, Langley SR. Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of Huntington's disease. EBioMedicine. 2023, 94:104720. 10.1016\/j.ebiom.2023.104720","journal-title":"EBioMedicine"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1177\/18796397251399701","article-title":"Insights into neurodevelopmental features of Huntington's disease from stem cell-derived models including organoids","volume":"15","author":"Sierra M","year":"2026","unstructured":"Sierra M, Powers R, Grotewold N, Paulson H. Insights into neurodevelopmental features of Huntington's disease from stem cell-derived models including organoids. J Huntingtons Dis. 2026, 15:214-25. 10.1177\/18796397251399701","journal-title":"J Huntingtons Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26851-2","article-title":"Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation","volume":"12","author":"Jin M","year":"2021","unstructured":"Jin M, Shiwaku H, Tanaka H, et al.. Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat Commun. 2021, 12:6565. 10.1038\/s41467-021-26851-2","journal-title":"Nat Commun"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112277","article-title":"PQBP1 regulates striatum development through balancing striatal progenitor proliferation and differentiation","volume":"42","author":"Liu W","year":"2023","unstructured":"Liu W, Xie H, Liu X, et al.. PQBP1 regulates striatum development through balancing striatal progenitor proliferation and differentiation. Cell Rep. 2023, 42:112277. 10.1016\/j.celrep.2023.112277","journal-title":"Cell Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3833-10.2011","article-title":"Functional connectome of the striatal medium spiny neuron","volume":"31","author":"Chuhma N","year":"2011","unstructured":"Chuhma N, Tanaka KF, Hen R, Rayport S. Functional connectome of the striatal medium spiny neuron. J Neurosci. 2011, 31:1183-92. 10.1523\/JNEUROSCI.3833-10.2011","journal-title":"J Neurosci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.04.029","article-title":"Huntingtin inclusions trigger cellular quiescence, deactivate apoptosis, and lead to delayed necrosis","volume":"19","author":"Ramdzan YM","year":"2017","unstructured":"Ramdzan YM, Trubetskov MM, Ormsby AR, et al.. Huntingtin inclusions trigger cellular quiescence, deactivate apoptosis, and lead to delayed necrosis. Cell Rep. 2017, 19:919-27. 10.1016\/j.celrep.2017.04.029","journal-title":"Cell Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/1073858420972662","article-title":"Synaptic dysfunction in Huntington's disease: lessons from genetic animal models","volume":"28","author":"Cepeda C","year":"2022","unstructured":"Cepeda C, Levine MS. Synaptic dysfunction in Huntington's disease: lessons from genetic animal models. Neuroscientist. 2022, 28:20-40. 10.1177\/1073858420972662","journal-title":"Neuroscientist"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00163","article-title":"Reduced fractalkine levels lead to striatal synaptic plasticity deficits in Huntington's disease","volume":"14","author":"Kim A","year":"2020","unstructured":"Kim A, Garc\u00eda-Garc\u00eda E, Straccia M, et al.. Reduced fractalkine levels lead to striatal synaptic plasticity deficits in Huntington's disease. Front Cell Neurosci. 2020, 14:163. 10.3389\/fncel.2020.00163","journal-title":"Front Cell Neurosci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00129","article-title":"Fractalkine regulation of microglial physiology and consequences on the brain and behavior","volume":"8","author":"Paolicelli RC","year":"2014","unstructured":"Paolicelli RC, Bisht K, Tremblay M\u00c8. Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci. 2014, 8:129. 10.3389\/fncel.2014.00129","journal-title":"Front Cell Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052510","article-title":"Brain organoid models of Huntington's disease shift the focus towards neurodevelopment","volume":"18","author":"Xu W","year":"2025","unstructured":"Xu W, Prigione A. Brain organoid models of Huntington's disease shift the focus towards neurodevelopment. Dis Model Mech. 2025, 18:10.1242\/dmm.052510","journal-title":"Dis Model Mech"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15060663","article-title":"Cortical and striatal functional connectivity in juvenile-onset Huntington's disease","volume":"15","author":"Barry A","year":"2025","unstructured":"Barry A, Nopoulos PC. Cortical and striatal functional connectivity in juvenile-onset Huntington's disease. Brain Sci. 2025, 15:663. 10.3390\/brainsci15060663","journal-title":"Brain Sci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.06.023","article-title":"Unmasking schizophrenia: synaptic pruning in adolescence reveals a latent physiological vulnerability in prefrontal recurrent networks","volume":"92","author":"Chafee MV","year":"2022","unstructured":"Chafee MV, Averbeck BB. Unmasking schizophrenia: synaptic pruning in adolescence reveals a latent physiological vulnerability in prefrontal recurrent networks. Biol Psychiatry. 2022, 92:436-9. 10.1016\/j.biopsych.2022.06.023","journal-title":"Biol Psychiatry"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.769184","article-title":"Molecular strategies to target protein aggregation in Huntington's disease","volume":"8","author":"Jarosi\u0144ska OD","year":"2021","unstructured":"Jarosi\u0144ska OD, R\u00fcdiger SG. Molecular strategies to target protein aggregation in Huntington's disease. Front Mol Biosci. 2021, 8:769184. 10.3389\/fmolb.2021.769184","journal-title":"Front Mol Biosci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.837576","article-title":"Polyglutamine expansion in huntingtin and mechanism of DNA damage repair defects in Huntington's disease","volume":"16","author":"Pradhan S","year":"2022","unstructured":"Pradhan S, Gao R, Bush K, Zhang N, Wairkar YP, Sarkar PS. Polyglutamine expansion in huntingtin and mechanism of DNA damage repair defects in Huntington's disease. Front Cell Neurosci. 2022, 16:837576. 10.3389\/fncel.2022.837576","journal-title":"Front Cell Neurosci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1042\/BST20180025","article-title":"Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention","volume":"46","author":"Briston T","year":"2018","unstructured":"Briston T, Hicks AR. Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention. Biochem Soc Trans. 2018, 46:829-42. 10.1042\/BST20180025","journal-title":"Biochem Soc Trans"},{"key":"ref50","article-title":"Exploring protein misfolding and aggregate pathology in neurodegenerative diseases: from molecular mechanisms to clinical interventions","volume":"15","author":"Johnson JT","year":"2025","unstructured":"Johnson JT, Awosiminiala FW, Anumudu CK. Exploring protein misfolding and aggregate pathology in neurodegenerative diseases: from molecular mechanisms to clinical interventions. Appl Sci (Basel). 2025, 15:10285.","journal-title":"Appl Sci (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003802","article-title":"Protein aggregation in neurodegenerative diseases","volume":"138","author":"Wang J","year":"2025","unstructured":"Wang J, Dai L, Zhang Z. Protein aggregation in neurodegenerative diseases. Chin Med J (Engl). 2025, 138:2753-68. 10.1097\/CM9.0000000000003802","journal-title":"Chin Med J (Engl)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddad098","article-title":"Juvenile and adult expression of polyglutamine expanded huntingtin produce distinct aggregate distributions in Drosophila muscle","volume":"32","author":"Barwell T","year":"2023","unstructured":"Barwell T, Raina S, Page A, MacCharles H, Seroude L. Juvenile and adult expression of polyglutamine expanded huntingtin produce distinct aggregate distributions in Drosophila muscle. Hum Mol Genet. 2023, 32:2656-68. 10.1093\/hmg\/ddad098","journal-title":"Hum Mol Genet"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.81","article-title":"Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin","volume":"20","author":"Tan Z","year":"2015","unstructured":"Tan Z, Dai W, van Erp TG, et al.. Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin. Mol Psychiatry. 2015, 20:1286-93. 10.1038\/mp.2015.81","journal-title":"Mol Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet J","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, et al.. Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology. Ann Neurol. 2015, 78:160-77. 10.1002\/ana.24406","journal-title":"Ann Neurol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083532","article-title":"Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction","volume":"26","author":"Gryka-Marton M","year":"2025","unstructured":"Gryka-Marton M, Grabowska AD, Szukiewicz D. Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction. Int J Mol Sci. 2025, 26:3532. 10.3390\/ijms26083532","journal-title":"Int J Mol Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.04.021","article-title":"Huntington's disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits","volume":"19","author":"Lim RG","year":"2017","unstructured":"Lim RG, Quan C, Reyes-Ortiz AM, et al.. Huntington's disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits. Cell Rep. 2017, 19:1365-77. 10.1016\/j.celrep.2017.04.021","journal-title":"Cell Rep"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1305790","article-title":"Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications","volume":"15","author":"Tan S","year":"2023","unstructured":"Tan S, Chen W, Kong G, Wei L, Xie Y. Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications. Front Aging Neurosci. 2023, 15:1305790. 10.3389\/fnagi.2023.1305790","journal-title":"Front Aging Neurosci"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-014-1811-2","article-title":"Novel insights into the development and maintenance of the blood-brain barrier","volume":"355","author":"Engelhardt B","year":"2014","unstructured":"Engelhardt B, Liebner S. Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res. 2014, 355:687-99. 10.1007\/s00441-014-1811-2","journal-title":"Cell Tissue Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.08.007","article-title":"The blood-brain barrier in neuroimmunology: tales of separation and assimilation","volume":"44","author":"Banks WA","year":"2015","unstructured":"Banks WA. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun. 2015, 44:1-8. 10.1016\/j.bbi.2014.08.007","journal-title":"Brain Behav Immun"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1626082","article-title":"Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?","volume":"16","author":"Kumar M","year":"2025","unstructured":"Kumar M, Yip L, Wang F, Marty SE, Fathman CG. Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?. Front Immunol. 2025, 16:1626082. 10.3389\/fimmu.2025.1626082","journal-title":"Front Immunol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-022-00347-7","article-title":"Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington's disease","volume":"19","author":"Linville RM","year":"2022","unstructured":"Linville RM, Nerenberg RF, Grifno G, Arevalo D, Guo Z, Searson PC. Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington's disease. Fluids Barriers CNS. 2022, 19:54. 10.1186\/s12987-022-00347-7","journal-title":"Fluids Barriers CNS"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2018.11","article-title":"Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities","volume":"39","author":"Harding RJ","year":"2018","unstructured":"Harding RJ, Tong YF. Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities. Acta Pharmacol Sin. 2018, 39:754-69. 10.1038\/aps.2018.11","journal-title":"Acta Pharmacol Sin"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19538-0","article-title":"Dynamic recruitment of ubiquitin to mutant huntingtin inclusion bodies","volume":"8","author":"Juenemann K","year":"2018","unstructured":"Juenemann K, Jansen AH, van Riel L, et al.. Dynamic recruitment of ubiquitin to mutant huntingtin inclusion bodies. Sci Rep. 2018, 8:1405. 10.1038\/s41598-018-19538-0","journal-title":"Sci Rep"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1760014","article-title":"Impact of differential and time-dependent autophagy activation on therapeutic efficacy in a model of Huntington disease","volume":"17","author":"Bratt\u00e5s PL","year":"2021","unstructured":"Bratt\u00e5s PL, Hersbach BA, Madsen S, Petri R, Jakobsson J, Pircs K. Impact of differential and time-dependent autophagy activation on therapeutic efficacy in a model of Huntington disease. Autophagy. 2021, 17:1316-29. 10.1080\/15548627.2020.1760014","journal-title":"Autophagy"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara T","year":"2006","unstructured":"Hara T, Nakamura K, Matsui M, et al.. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006, 441:885-9. 10.1038\/nature04724","journal-title":"Nature"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"Wellington CL","year":"2002","unstructured":"Wellington CL, Ellerby LM, Gutekunst CA, et al.. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci. 2002, 22:7862-72. 10.1523\/JNEUROSCI.22-18-07862.2002","journal-title":"J Neurosci"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.00108s3511","article-title":"Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models","volume":"108","author":"Rice D","year":"2000","unstructured":"Rice D, Barone S Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000, 108:511-33. 10.1289\/ehp.00108s3511","journal-title":"Environ Health Perspect"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2018.11.006","article-title":"Targeting the proteostasis network in Huntington's disease","volume":"49","author":"Soares TR","year":"2019","unstructured":"Soares TR, Reis SD, Pinho BR, Duchen MR, Oliveira JM. Targeting the proteostasis network in Huntington's disease. Ageing Res Rev. 2019, 49:92-103. 10.1016\/j.arr.2018.11.006","journal-title":"Ageing Res Rev"},{"key":"ref69","article-title":"Brain plasticity and behaviour in the developing brain","volume":"20","author":"Kolb B","year":"2011","unstructured":"Kolb B, Gibb R. Brain plasticity and behaviour in the developing brain. J Can Acad Child Adolesc Psychiatry. 2011, 20:265-76.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1532244100","article-title":"Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain","volume":"100","author":"Curtis MA","year":"2003","unstructured":"Curtis MA, Penney EB, Pearson AG, et al.. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A. 2003, 100:9023-7. 10.1073\/pnas.1532244100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-71779-1_3","article-title":"Mitochondrial dysfunction in Huntington\u2019s disease","author":"Carmo C","year":"2018","unstructured":"Carmo C, Naia L, Lopes C, Rego AC. Mitochondrial dysfunction in Huntington\u2019s disease. Polyglutamine Disorders. Advances in Experimental Medicine and Biology. N\u00f3brega C, de Almeida LP (ed): Springer, Cham; 2018. 1049:59-83. 10.1007\/978-3-319-71779-1_3"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1093\/oons\/kvad004","article-title":"Energy metabolic pathways in neuronal development and function","volume":"2","author":"Rumpf S","year":"2023","unstructured":"Rumpf S, Sanal N, Marzano M. Energy metabolic pathways in neuronal development and function. Oxf Open Neurosci. 2023, 2:kvad004. 10.1093\/oons\/kvad004","journal-title":"Oxf Open Neurosci"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2023.03.001","article-title":"A comprehensive perspective of Huntington's disease and mitochondrial dysfunction","volume":"70","author":"Dai Y","year":"2023","unstructured":"Dai Y, Wang H, Lian A, Li J, Zhao G, Hu S, Li B. A comprehensive perspective of Huntington's disease and mitochondrial dysfunction. Mitochondrion. 2023, 70:8-19. 10.1016\/j.mito.2023.03.001","journal-title":"Mitochondrion"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-170264","article-title":"Towards an understanding of energy impairment in Huntington's disease brain","volume":"6","author":"Dubinsky JM","year":"2017","unstructured":"Dubinsky JM. Towards an understanding of energy impairment in Huntington's disease brain. J Huntingtons Dis. 2017, 6:267-302. 10.3233\/JHD-170264","journal-title":"J Huntingtons Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1042\/bst0221002","article-title":"Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases","volume":"22","author":"Browne SE","year":"1994","unstructured":"Browne SE, Beal MF. Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases. Biochem Soc Trans. 1994, 22:1002-6. 10.1042\/bst0221002","journal-title":"Biochem Soc Trans"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000197","article-title":"Abnormalities in the tricarboxylic acid cycle in Huntington disease and in a Huntington disease mouse model","volume":"74","author":"Naseri NN","year":"2015","unstructured":"Naseri NN, Xu H, Bonica J, et al.. Abnormalities in the tricarboxylic acid cycle in Huntington disease and in a Huntington disease mouse model. J Neuropathol Exp Neurol. 2015, 74:527-37. 10.1097\/NEN.0000000000000197","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.249218","article-title":"Mitophagy links oxidative stress conditions and neurodegenerative diseases","volume":"14","author":"Shefa U","year":"2019","unstructured":"Shefa U, Jeong NY, Song IO, Chung HJ, Kim D, Jung J, Huh Y. Mitophagy links oxidative stress conditions and neurodegenerative diseases. Neural Regen Res. 2019, 14:749-56. 10.4103\/1673-5374.249218","journal-title":"Neural Regen Res"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.2174\/1389450122666210224105945","article-title":"Mitochondrial dysfunction in Huntington's disease: pathogenesis and therapeutic opportunities","volume":"22","author":"Sharma A","year":"2021","unstructured":"Sharma A, Behl T, Sharma L, Aelya L, Bungau S. Mitochondrial dysfunction in Huntington's disease: pathogenesis and therapeutic opportunities. Curr Drug Targets. 2021, 22:1637-67. 10.2174\/1389450122666210224105945","journal-title":"Curr Drug Targets"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-180306","article-title":"Assessment of the performance of a modified motor scale as applied to juvenile onset Huntington's disease","volume":"8","author":"Horton MC","year":"2019","unstructured":"Horton MC, Nopoulos P, Nance M, et al.. Assessment of the performance of a modified motor scale as applied to juvenile onset Huntington's disease. J Huntingtons Dis. 2019, 8:181-93. 10.3233\/JHD-180306","journal-title":"J Huntingtons Dis"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1371\/4f8606b742ef3","article-title":"The prevalence of juvenile Huntington's disease: a review of the literature and meta-analysis","volume":"4","author":"Quarrell O","year":"2012","unstructured":"Quarrell O, O'Donovan KL, Bandmann O, Strong M. The prevalence of juvenile Huntington's disease: a review of the literature and meta-analysis. PLoS Curr. 2012, 4:e4f8606b742ef3. 10.1371\/4f8606b742ef3","journal-title":"PLoS Curr"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1177\/11795735221092517","article-title":"Current and possible future therapeutic options for Huntington's disease","volume":"14","author":"Ferguson MW","year":"2022","unstructured":"Ferguson MW, Kennedy CJ, Palpagama TH, Waldvogel HJ, Faull RL, Kwakowsky A. Current and possible future therapeutic options for Huntington's disease. J Cent Nerv Syst Dis. 2022, 14:11795735221092517. 10.1177\/11795735221092517","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1304","article-title":"Current pharmacological management in juvenile Huntington's disease","volume":"4","author":"Robertson L","year":"2012","unstructured":"Robertson L, Santini H, O'Donovan KL, et al.. Current pharmacological management in juvenile Huntington's disease. PLoS Curr. 2012, 4:RRN1304. 10.1371\/currents.RRN1304","journal-title":"PLoS Curr"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2021.100470","article-title":"Juvenile Huntington's disease masquerading as progressive myoclonus epilepsy","volume":"16","author":"Thakor B","year":"2021","unstructured":"Thakor B, Jagtap SA, Joshi A. Juvenile Huntington's disease masquerading as progressive myoclonus epilepsy. Epilepsy Behav Rep. 2021, 16:100470. 10.1016\/j.ebr.2021.100470","journal-title":"Epilepsy Behav Rep"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25237","article-title":"Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort","volume":"27","author":"Cloud LJ","year":"2012","unstructured":"Cloud LJ, Rosenblatt A, Margolis RL, et al.. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Mov Disord. 2012, 27:1797-800. 10.1002\/mds.25237","journal-title":"Mov Disord"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Roos RA","year":"2010","unstructured":"Roos RA. Huntington's disease: a clinical review. Orphanet J Rare Dis. 2010, 5:40. 10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.11.004","article-title":"Psychotropic medication use in Huntington's disease: a retrospective cohort study","volume":"105","author":"Andriessen RL","year":"2022","unstructured":"Andriessen RL, Oosterloo M, Hollands A, Linden DE, de Greef BT, Leentjens AF. Psychotropic medication use in Huntington's disease: a retrospective cohort study. Parkinsonism Relat Disord. 2022, 105:69-74. 10.1016\/j.parkreldis.2022.11.004","journal-title":"Parkinsonism Relat Disord"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2006.00921.x","article-title":"Juvenile Huntington disease","volume":"42","author":"Geevasinga N","year":"2006","unstructured":"Geevasinga N, Richards FH, Jones KJ, Ryan MM. Juvenile Huntington disease. J Paediatr Child Health. 2006, 42:552-4. 10.1111\/j.1440-1754.2006.00921.x","journal-title":"J Paediatr Child Health"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.931636","article-title":"Time-restricted ketogenic diet in Huntington's disease: a case study","volume":"16","author":"Phillips MC","year":"2022","unstructured":"Phillips MC, McManus EJ, Brinkhuis M, Romero-Ferrando B. Time-restricted ketogenic diet in Huntington's disease: a case study. Front Behav Neurosci. 2022, 16:931636. 10.3389\/fnbeh.2022.931636","journal-title":"Front Behav Neurosci"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/9.7.487","article-title":"Dieting in adolescence","volume":"9","author":"Whyte HEA","year":"2004","unstructured":"Whyte HEA, Findlay S, Society CP, Committee AH. Dieting in adolescence. Paediatr Child Health. 2004, 9:487-503. 10.1093\/pch\/9.7.487","journal-title":"Paediatr Child Health"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adv0702","article-title":"Selective targeting of mutant huntingtin intron 1 improves rescue provided by antisense oligonucleotides in Huntington's disease mice","volume":"18","author":"Bragg RM","year":"2026","unstructured":"Bragg RM, Landles C, Smith EJ, et al.. Selective targeting of mutant huntingtin intron 1 improves rescue provided by antisense oligonucleotides in Huntington's disease mice. Sci Transl Med. 2026, 18:eadv0702. 10.1126\/scitranslmed.adv0702","journal-title":"Sci Transl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523170-mechanistic-differences-in-adult-onset-and-juvenile-onset-huntingtons-disease-and-the-potential-role-of-neurodevelopment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:41:37Z","timestamp":1790721697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523170-mechanistic-differences-in-adult-onset-and-juvenile-onset-huntingtons-disease-and-the-potential-role-of-neurodevelopment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":90,"URL":"https:\/\/doi.org\/10.7759\/cureus.117175","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}